Verflixt! Es sieht so aus, als wenn Sie einen veralteten Browser benutzen. Wir empfehlen Ihnen dringend Ihren Browser zu aktualisieren.
Weitere Informationen über Browser und Updates finden Sie hier

Oncotest GmbH

Since November 2015, Oncotest is a subsidiary of Charles River Laboratories International, Inc., a leading CRO in early development.
Oncotest was founded in 1993 by Prof. H.-H. Fiebig as a spin-off of the Department of Internal Medicine of the University of Freiburg. Today, we are a mid-sized company specializing in preclinical pharmacological contract research. All our experimental units are located at one site in Freiburg, Germany- we are currently expanding our capacities with the construction of a second building. Our AAALAC accredited in vivo facility consists of two separate units for model development and therapy experiments.
Prof. Fiebig’s 30 years of experience in cancer research and xenografts have led to the establishment of a unique collection of more than 350 patient-derived tumor models that are available for in vivo studies in nude mice as well as a wide spectrum of other services, including 2D and 3D in vitro assays and biomarker development.
Our experienced scientists and the project management team offer guidance on choosing the relevant tumor models and testing assays that fit your needs.



Oncotest GmbH

Am Flughafen 12-14
79108 Freiburg
Forschung & Entwicklung
Sonstige Tätigkeitsfelder